MGRX DEF 14A: Board change
Mangoceuticals
Filed with the SEC on · accession 0001493152-26-052901
MGRX filed a DEF 14A (proxy statement) with the SEC on Nov 17, 2026. Mangoceuticals filed a definitive proxy statement for its combined 2025/2026 annual meeting, asking stockholders to elect four incumbent directors, approve a reverse stock split with a ratio between 1-for-2 and 1-for-25, approve an amendment to the 2022 Equity Incentive Plan, and ratify the… The stock moved -0.2% by the first close after the filing.
Summary of the filing
Mangoceuticals filed a definitive proxy statement for its combined 2025/2026 annual meeting, asking stockholders to elect four incumbent directors, approve a reverse stock split with a ratio between 1-for-2 and 1-for-25, approve an amendment to the 2022 Equity Incentive Plan, and ratify the appointment of Turner, Stone & Company as independent auditors.
Key details
How MGRX stock reacted
Close before
$0.16
Nov 16, 2026
First close after
-0.19%
$0.16
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MGRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MGRX?
Click hereFrequently asked questions
What did MGRX file with the SEC on Nov 17, 2026?
MGRX filed a DEF 14A (Board change). Mangoceuticals filed a definitive proxy statement for its combined 2025/2026 annual meeting, asking stockholders to elect four incumbent directors, approve a reverse stock split with a ratio between 1-for-2 and 1-for-25, approve an amendment to the 2022 Equity Incentive Plan, and ratify the appointment of Turner, Stone & Company as independent auditors.
What does a board change mean for MGRX stock?
Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.
How do I read a DEF 14A?
Information for the shareholder meeting: votes, board members and executive pay. Executive pay tables show how management is paid. Check the items shareholders vote on (mergers, new share plans).
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A DEF 14A (proxy statement): Information for the shareholder meeting: votes, board members and executive pay.
How did MGRX stock react to this filing?
MGRX closed at $0.16 before the filing and $0.16 on Nov 17, 2026 (-0.19%).
Other MGRX SEC filings
- 10-Q · SEC filingNov 16, 2026
- 8-K · SEC filingNov 13, 2026
- 8-K · SEC filingNov 6, 2026
- 424B5 · Secondary offeringOct 9, 2026
- 8-K · Secondary offeringOct 9, 2026
- SCHEDULE 13D/A · SEC filingOct 6, 2026
- 8-K · Material agreementOct 1, 2026
- 8-K · Contract lossAug 21, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · Delisting noticeAug 4, 2026
Get alerts when MGRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days